share_log

浙江医药(600216.SH):公司NMN产品目前仅对部分允许将该产品作为保健品销售的境外国家或地区出口销售

Zhejiang Pharmaceutical (600216.SH): Currently, the company's NMN products are only exported and sold to some overseas countries or regions that allow the product to be sold as a health product

Gelonghui Finance ·  Mar 29 06:40

Gelonghui, March 29丨Zhejiang Pharmaceutical (600216.SH) said on the investor interactive platform that NMN products cannot be registered and sold as pharmaceuticals or health products under current domestic regulations. Currently, the company's NMN products are only exported and sold to some overseas countries or regions that allow the product to be sold as health products. This business is an export/cross-border business being cultivated by the company's health products sector, and sales volume in 2023 will not be significant.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment